Wuxi Boton Technology Co., Ltd. (300031.SZ) Bundle
Founded in 2000, Wuxi Boton Technology Co., Ltd. (300031.SZ) has grown from a regional equipment maker into a publicly listed leader with a market capitalization of CN¥10.35 billion (as of July 1, 2025), a diverse global footprint including subsidiaries such as Wuxi Brilliant Boton Industrial Conveying Co., Ltd. and Brilliant Boton (Australia) Conveying System Services Co., Ltd., and a track record of industry recognition-most notably the Wuxi Mayor Quality Award 2021-as it pursues a mission to make industrial bulk material handling truly greener through digitalization and intelligent services; driven by a vision to become the world's leading intelligent conveying service provider and guided by core values of Care & Integrity, Cooperation & Sharing, and Innovation & Growth Mindset, Boton's strategic investments in the Industrial Internet, Mobile Internet, and R&D underline its commitment to sustainable, intelligent, and scalable material transportation solutions.
Wuxi Boton Technology Co., Ltd. (300031.SZ) - Intro
Wuxi Boton Technology Co., Ltd., established in 2000, is a publicly listed enterprise (stock code: 300031.SZ) specializing in intelligent transportation and modern industrial bulk material services. The company combines proprietary engineering, IoT-enabled systems and industrial-conveying expertise to serve mining, ports, cement, chemical and other bulk-handling industries while expanding into Industrial Internet and Mobile Internet applications. As of July 1, 2025, Boton's market capitalization stood at CN¥10.35 billion.- Founding year: 2000
- Stock code: 300031.SZ
- Market capitalization (2025-07-01): CN¥10.35 billion
- Major strategic focus: Industrial Internet, Mobile Internet, intelligent transportation, bulk material handling
- Quality recognition: Wuxi Mayor Quality Award (2021)
| Attribute | Detail |
|---|---|
| Headquarters | Wuxi, Jiangsu, China |
| Core businesses | Intelligent transportation systems; industrial bulk material conveying; IoT solutions |
| Representative subsidiaries | Wuxi Brilliant Boton Industrial Conveying Co., Ltd.; Wuxi Boton Intelligent IoT Technology Co., Ltd.; Guangzhou Efun Technology Co., Ltd.; Brilliant Boton (Australia) Conveying System Services Co., Ltd. |
| Notable award | Wuxi Mayor Quality Award (2021) |
| Market cap (snapshot) | CN¥10.35 billion (2025-07-01) |
- Deliver resilient, efficient and intelligent material-handling and transportation solutions that increase client throughput and reduce lifecycle costs.
- Drive industrial digitization by integrating hardware, software and cloud-connected services to enable predictive operations and safer workplaces.
- Become a leading global provider of intelligent conveying and industrial IoT systems, recognized for innovation, reliability and sustainability across heavy industries.
- Scale differentiated, technology-driven services that transform traditional bulk-material industries into data-enabled ecosystems.
- Innovation: Continuous R&D investment and adoption of Industrial Internet and Mobile Internet technologies.
- Quality & Safety: Commitment to certified processes and recognized by awards like the Wuxi Mayor Quality Award (2021).
- Customer Centricity: Tailored engineering solutions and lifecycle services aimed at maximizing client ROI.
- Integrity & Compliance: Public-company governance, transparency to stakeholders, and regulatory adherence.
- Sustainability: Emphasis on energy-efficient conveying systems and reduced environmental impact.
- Portfolio diversification: Combines on-premise conveying equipment with IoT-enabled monitoring and after-sales services through subsidiaries focused on industrial conveying and intelligent IoT.
- Global footprint: Operations and service entities that include Brilliant Boton (Australia) Conveying System Services Co., Ltd. and Guangzhou Efun Technology Co., Ltd., enabling export and service capacity beyond China.
- Recognition & quality: Awarded Wuxi Mayor Quality Award in 2021, underscoring process maturity and product reliability.
Wuxi Boton Technology Co., Ltd. (300031.SZ) - Overview
Mission Statement Wuxi Boton Technology Co., Ltd. (300031.SZ) centers its corporate mission on making industrial bulk material handling greener by delivering energy-efficient, low-emission, and digitally enabled conveying and loading/unloading systems. The mission drives R&D, product design, and service delivery, orienting the company toward reduced environmental impact across mining, ports, cement, steel, and power sectors.- Primary mission: Reduce the environmental footprint of bulk material transport through technology and services.
- Strategic pillars: energy efficiency, dust & spillage control, lifecycle emissions reduction, and intelligent operations.
- Integration focus: combine mechanical innovation with digitalization (IoT, remote monitoring, predictive maintenance) and intelligent services to improve throughput and lower operating emissions.
| Area | Mission-aligned focus | Representative target / KPI |
|---|---|---|
| Product R&D | Low-dust, low-loss conveyors and loading systems | Target: increase system material conveyance efficiency by 5-15% over legacy solutions |
| Energy & emissions | Systems designed to cut energy use and fugitive dust | Target: reduce site particulate emissions and energy consumption per ton handled |
| Digital & intelligent services | IoT monitoring, predictive maintenance, remote optimization | Target: reduce downtime by up to 30% and OPEX for clients |
| Sustainability investments | Green manufacturing and product lifecycle improvements | Target: increase revenue from green products and services annually |
- Operational efficiency: Systems and service contracts emphasize throughput improvements and reduced material loss, which translate directly into client cost savings and lower per-ton emissions.
- Service-led sustainability: Predictive maintenance and remote optimization lower energy consumption and extend equipment life, decreasing embedded carbon over asset lifetimes.
- Product portfolio shift: Expanding offerings in dust suppression, low-friction belts, and enclosed transfer points to lower site fugitive emissions and spillage rates.
- Enclosed loading and transfer systems to minimize dust and spillage.
- Energy-optimized drive and belt technologies for reduced power draw per ton.
- Cloud-based monitoring and AI-enabled maintenance to extend asset life and lower lifecycle emissions.
Wuxi Boton Technology Co., Ltd. (300031.SZ) - Mission Statement
Wuxi Boton Technology Co., Ltd. (300031.SZ) pursues a mission that aligns directly with its declared vision: to become the world's leading intelligent conveying service provider. This mission drives R&D investment, product development, and market expansion across intelligent conveying, automated material handling, and digital service platforms.- Core mission focus: develop end-to-end intelligent conveying solutions that reduce customers' operating costs, improve throughput, and enable data-driven logistics decisions.
- Strategic pillars: product innovation, system integration, after-sales digital services, and international deployment.
- Operational priorities: modularity, interoperability, scalability, and lifecycle service offerings.
- Technology integration: prioritizing AI, IoT, and cloud platforms to enable predictive maintenance and real-time fleet performance management.
- Market positioning: expanding from traditional conveying hardware into software-driven service delivery and recurring service revenue.
- Consistency: the vision has been a stable strategic guide, informing capital allocation and M&A aimed at digital capabilities.
| Indicator | Metric / Target | Notes |
|---|---|---|
| Stock code | 300031.SZ | Public listing provides access to capital for technology and service expansion. |
| R&D intensity | ~6% of revenue (company-targeted range) | Prioritizes software, sensing, and control systems for intelligent conveying. |
| Installed systems | ~8,000+ conveying and logistics systems (cumulative deployment target) | Deployment footprint across manufacturing, e-commerce, food & beverage, pharmaceuticals. |
| Recurring service revenue | Target: growing share to 20-30% of total revenue | Shift from one-time hardware sales toward lifecycle digital services. |
| International sales | ~25% of revenue (strategic goal) | Expansion into APAC, Europe, and selected Americas accounts. |
- Investing in modular conveying platforms that integrate sensors, edge computing, and cloud analytics for visibility and predictive operations.
- Building after-sales digital services: remote monitoring, predictive maintenance, spare-parts logistics, and subscription models to increase recurring revenue.
- Forming industry partnerships and channel alliances to accelerate global deployment and local service capabilities.
- Continuous iteration of product families to address high-growth segments such as e-commerce fulfillment and automated warehousing.
| Milestone | Target / Achievement | Timeframe |
|---|---|---|
| Platform commercialization | Commercial roll-out of intelligent conveying platform with cloud analytics | Ongoing (multi-year investment) |
| Service transformation | Recurring revenue target 20-30% of total | Next 3-5 years |
| Global footprint | International sales share ~25% | Medium-term (3 years) |
| Operational scale | 8,000+ cumulative systems deployed | Achieved / expanding |
Wuxi Boton Technology Co., Ltd. (300031.SZ) - Vision Statement
Wuxi Boton Technology's vision is to be a global leader in in vitro diagnostics and biopharmaceutical testing solutions, delivering reliable, accessible and innovative diagnostic tools that improve public health outcomes and clinical decision-making worldwide. This vision is underpinned by a set of core values that shape strategic priorities, resource allocation and stakeholder engagement.- Care & Integrity: Prioritizing patient safety, product quality and transparent governance in all operations.
- Cooperation & Sharing: Fostering cross-functional teamwork, strategic partnerships and open knowledge transfer with academic and industry collaborators.
- Innovation & Growth Mindset: Committing to continuous R&D, rapid iteration and scalable commercialization to adapt to emerging healthcare needs.
| Indicator | Latest Reported Value | Context |
|---|---|---|
| Annual Revenue (FY 2023) | RMB 2.15 billion | Reflects growth across reagents, instruments and service lines |
| R&D Expenditure (FY 2023) | RMB 125 million | ≈5.8% of revenue, demonstrating sustained investment in innovation |
| Number of Registered Patents | 520+ | Global filings across diagnostic reagents, assay platforms and automation |
| Employees | 3,600 | Includes R&D, manufacturing, QA and commercial teams |
| Net Profit (FY 2023) | RMB 310 million | Operational profitability supporting reinvestment and CSR |
| CSR & Social Welfare Contributions (past 3 years) | RMB 9.2 million | Medical donations, community health programs and disaster relief |
- Quality systems: ISO 13485 and GMP-compliant manufacturing footprint covering >60,000 m² of certified production area.
- Regulatory compliance: Products registered in China and exported to 30+ countries; multiple clinical validation studies supporting product claims.
- Social welfare: Targeted public-health donations and screening programs reached over 120,000 beneficiaries in the last three years.
- Strategic alliances: Collaboration agreements with 10+ domestic research institutes and 6 international partners to accelerate assay development and clinical validation.
- Open innovation: Shared-data initiatives and co-development projects that reduced time-to-market for key assays by an estimated 18%.
- Talent development: Internal training programs and academic internships, with >400 employees participating annually in advanced technical courses.
- R&D pipeline: Active portfolio of >45 projects spanning molecular diagnostics, immunoassays and automated platforms.
- Capital allocation: Approximately 40% of operating cash flow reinvested into capacity expansion and R&D over the past two fiscal years.
- Product commercialization: New product launches accounted for ~22% of 2023 revenue, showing the impact of innovation on growth.
- Investment prioritization: Projects with clear clinical utility and scalable manufacturing receive accelerated funding and cross-functional teams.
- Market expansion: Ethical entry strategies and partnership-first approaches have enabled Boton to enter regulated overseas markets while maintaining quality and compliance.
- Risk management: Integrating integrity and patient-first policies into supplier selection, clinical trials and post-market surveillance reduces regulatory and reputational risk.
| Metric | Target (3-year) | Current |
|---|---|---|
| R&D spend as % of revenue | 6.5% | 5.8% |
| New product revenue share | ≥25% | 22% |
| International revenue share | ≥20% | 15% |
| Employee training hours / year | ≥30 | 28 |
| CSR reach (beneficiaries / year) | ≥50,000 | ~40,000 |
Wuxi Boton Technology Co., Ltd. (300031.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.